Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malformations of Cortical Development | 3 | 2026 | 46 | 1.230 |
Why?
|
| Polymicrogyria | 2 | 2026 | 12 | 1.140 |
Why?
|
| Coronary Vessels | 1 | 2024 | 178 | 0.730 |
Why?
|
| Neuroimaging | 3 | 2020 | 143 | 0.640 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 387 | 0.580 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2026 | 3605 | 0.550 |
Why?
|
| Intellectual Disability | 4 | 2026 | 202 | 0.500 |
Why?
|
| Epilepsy | 4 | 2025 | 429 | 0.470 |
Why?
|
| Hypothermia, Induced | 3 | 2023 | 95 | 0.460 |
Why?
|
| Basal Ganglia Diseases | 1 | 2013 | 8 | 0.400 |
Why?
|
| Child, Preschool | 11 | 2026 | 4001 | 0.390 |
Why?
|
| Brain | 9 | 2025 | 2430 | 0.370 |
Why?
|
| Hyperglycemia | 1 | 2013 | 186 | 0.360 |
Why?
|
| Neocortex | 2 | 2023 | 100 | 0.320 |
Why?
|
| Mutation, Missense | 3 | 2023 | 302 | 0.300 |
Why?
|
| Developmental Disabilities | 3 | 2026 | 211 | 0.300 |
Why?
|
| Infant | 7 | 2026 | 3328 | 0.290 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2021 | 94 | 0.280 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2019 | 59 | 0.280 |
Why?
|
| Cerebral Cortex | 2 | 2025 | 571 | 0.280 |
Why?
|
| Choroid Plexus | 2 | 2024 | 16 | 0.250 |
Why?
|
| Mosaicism | 2 | 2025 | 74 | 0.250 |
Why?
|
| Child | 9 | 2026 | 7681 | 0.250 |
Why?
|
| Acupuncture | 1 | 2005 | 3 | 0.240 |
Why?
|
| Neurons | 4 | 2025 | 1619 | 0.230 |
Why?
|
| Nervous System Malformations | 1 | 2026 | 49 | 0.230 |
Why?
|
| Cerebellar Ataxia | 1 | 2026 | 28 | 0.230 |
Why?
|
| Humans | 32 | 2026 | 98076 | 0.230 |
Why?
|
| Adolescent | 9 | 2026 | 10079 | 0.230 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2025 | 1 | 0.230 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2024 | 5 | 0.220 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2025 | 52 | 0.210 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2025 | 63 | 0.210 |
Why?
|
| Retrospective Studies | 9 | 2026 | 10972 | 0.210 |
Why?
|
| Male | 19 | 2026 | 47075 | 0.210 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2025 | 220 | 0.210 |
Why?
|
| Genetic Testing | 2 | 2026 | 594 | 0.210 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2023 | 59 | 0.210 |
Why?
|
| Cerebellum | 1 | 2026 | 253 | 0.210 |
Why?
|
| Stroke | 1 | 2013 | 1154 | 0.200 |
Why?
|
| Vascular Calcification | 1 | 2024 | 48 | 0.200 |
Why?
|
| Epilepsies, Partial | 1 | 2023 | 52 | 0.200 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2023 | 10 | 0.200 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2023 | 59 | 0.190 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 27 | 0.180 |
Why?
|
| Health Status Disparities | 1 | 2025 | 234 | 0.180 |
Why?
|
| Congenital Abnormalities | 1 | 2022 | 69 | 0.180 |
Why?
|
| Pedigree | 5 | 2026 | 980 | 0.180 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2021 | 11 | 0.180 |
Why?
|
| Mutation | 7 | 2026 | 4392 | 0.180 |
Why?
|
| Central Nervous System Diseases | 1 | 2021 | 36 | 0.170 |
Why?
|
| Cardiomyopathies | 1 | 2025 | 315 | 0.170 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2023 | 137 | 0.170 |
Why?
|
| Female | 17 | 2026 | 51535 | 0.170 |
Why?
|
| Homozygote | 4 | 2026 | 212 | 0.170 |
Why?
|
| Electroencephalography | 2 | 2023 | 789 | 0.170 |
Why?
|
| Vesicular Transport Proteins | 2 | 2018 | 71 | 0.170 |
Why?
|
| Facies | 2 | 2018 | 33 | 0.170 |
Why?
|
| Cohort Studies | 2 | 2026 | 3212 | 0.160 |
Why?
|
| Video Games | 1 | 2020 | 14 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 13 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2025 | 604 | 0.160 |
Why?
|
| Lissencephaly | 1 | 2020 | 24 | 0.150 |
Why?
|
| Netrins | 1 | 2019 | 6 | 0.150 |
Why?
|
| Retinitis Pigmentosa | 1 | 2019 | 37 | 0.150 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 57 | 0.150 |
Why?
|
| Brain Diseases | 2 | 2020 | 174 | 0.150 |
Why?
|
| Behavior Therapy | 1 | 2020 | 100 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2025 | 2585 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 137 | 0.150 |
Why?
|
| Transcriptome | 1 | 2025 | 820 | 0.150 |
Why?
|
| Calcium | 1 | 2024 | 1196 | 0.150 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 16 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 539 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 225 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2023 | 2529 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2020 | 245 | 0.140 |
Why?
|
| Fetal Development | 1 | 2018 | 37 | 0.140 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 17 | 0.140 |
Why?
|
| Cerebellar Diseases | 1 | 2018 | 23 | 0.140 |
Why?
|
| Genetic Variation | 2 | 2022 | 1445 | 0.140 |
Why?
|
| Telencephalon | 1 | 2017 | 31 | 0.130 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 104 | 0.130 |
Why?
|
| Fetus | 1 | 2018 | 237 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 403 | 0.130 |
Why?
|
| Epilepsy, Generalized | 1 | 2018 | 43 | 0.130 |
Why?
|
| Extracellular Vesicles | 1 | 2018 | 57 | 0.130 |
Why?
|
| Genome, Human | 1 | 2022 | 832 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2025 | 3620 | 0.130 |
Why?
|
| Phenotype | 5 | 2026 | 2638 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1285 | 0.120 |
Why?
|
| Risk Factors | 2 | 2025 | 6232 | 0.120 |
Why?
|
| Cell Movement | 1 | 2020 | 814 | 0.120 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2015 | 3 | 0.120 |
Why?
|
| Transcription Factor TFIID | 1 | 2015 | 4 | 0.120 |
Why?
|
| Adult | 9 | 2026 | 29538 | 0.120 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 45 | 0.120 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 45 | 0.120 |
Why?
|
| Stem Cells | 1 | 2017 | 396 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 59 | 0.110 |
Why?
|
| Young Adult | 7 | 2024 | 7507 | 0.110 |
Why?
|
| White Matter | 1 | 2016 | 100 | 0.110 |
Why?
|
| Heart Failure | 1 | 2025 | 1491 | 0.100 |
Why?
|
| Movement | 1 | 2016 | 313 | 0.100 |
Why?
|
| Dyskinesias | 1 | 2013 | 9 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2013 | 69 | 0.090 |
Why?
|
| Syndrome | 2 | 2026 | 438 | 0.090 |
Why?
|
| Siblings | 2 | 2023 | 113 | 0.080 |
Why?
|
| Genetic Association Studies | 2 | 2026 | 310 | 0.080 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 83 | 0.080 |
Why?
|
| Seizures | 2 | 2023 | 318 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1567 | 0.070 |
Why?
|
| Exome | 2 | 2019 | 145 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 512 | 0.070 |
Why?
|
| Biomarkers | 2 | 2025 | 2020 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1995 | 0.070 |
Why?
|
| Papillary Muscles | 1 | 2007 | 18 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2007 | 57 | 0.060 |
Why?
|
| Family | 2 | 2019 | 327 | 0.060 |
Why?
|
| Sequence Analysis | 1 | 2025 | 25 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2025 | 14 | 0.060 |
Why?
|
| Caribbean Region | 1 | 2025 | 28 | 0.060 |
Why?
|
| Protons | 1 | 2005 | 102 | 0.060 |
Why?
|
| Prealbumin | 1 | 2025 | 46 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2025 | 61 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2025 | 51 | 0.060 |
Why?
|
| Genotyping Techniques | 1 | 2025 | 72 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 304 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2025 | 108 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 2013 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2005 | 243 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2025 | 160 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2025 | 93 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2025 | 146 | 0.050 |
Why?
|
| Heart | 1 | 2007 | 527 | 0.050 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2025 | 151 | 0.050 |
Why?
|
| Time Factors | 2 | 2025 | 5567 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 71 | 0.050 |
Why?
|
| Retinal Degeneration | 1 | 2023 | 30 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2666 | 0.050 |
Why?
|
| Delayed Diagnosis | 1 | 2023 | 40 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2025 | 241 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 219 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 31 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 721 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2025 | 464 | 0.050 |
Why?
|
| Alleles | 1 | 2026 | 1159 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2023 | 218 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 208 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2005 | 376 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2025 | 540 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 285 | 0.040 |
Why?
|
| Mice | 3 | 2022 | 12698 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 86 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2021 | 50 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2021 | 94 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 126 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 370 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2024 | 555 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 1782 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 28894 | 0.040 |
Why?
|
| Centrioles | 1 | 2020 | 5 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 488 | 0.040 |
Why?
|
| Paraparesis, Spastic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Autophagy | 1 | 2021 | 177 | 0.040 |
Why?
|
| Hippocampus | 1 | 2023 | 462 | 0.040 |
Why?
|
| Microtubules | 1 | 2020 | 141 | 0.040 |
Why?
|
| Spinal Diseases | 1 | 2020 | 96 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2025 | 839 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 147 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 26 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 1302 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 113 | 0.030 |
Why?
|
| Hemimegalencephaly | 1 | 2017 | 4 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 29427 | 0.030 |
Why?
|
| Retina | 1 | 2019 | 221 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 804 | 0.030 |
Why?
|
| Gestational Age | 1 | 2018 | 340 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 367 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2036 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4116 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 390 | 0.030 |
Why?
|
| Apoptosis | 1 | 2022 | 1752 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 332 | 0.030 |
Why?
|
| E-Box Elements | 1 | 2015 | 7 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1962 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2015 | 55 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 2373 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 7389 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 568 | 0.020 |
Why?
|
| Zebrafish | 1 | 2015 | 353 | 0.020 |
Why?
|
| United States | 1 | 2025 | 8196 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 3244 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2555 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 9711 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2572 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2023 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21758 | 0.020 |
Why?
|
| Dogs | 1 | 2007 | 639 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 630 | 0.010 |
Why?
|